Skip to main content
. 2021 Jul 24;28(6):1225–1234. doi: 10.1007/s12282-021-01250-z

Fig. 4.

Fig. 4

RFS by TP53 signature status in subtypes of breast cancer and in grade. RFS stratified by TP53 status based on the TP53 signature score in patients with ER + (a), ER(−) (b), Luminal A like (c), Luminal B Like (d), TNBC (e), Grade 1 (f), Grade 2 (g) and Grade 3 (h) were constructed using the Kaplan–Meier method. The differences were compared using the log-rank test. The short vertical line on the curve represent censored. ER estrogen receptor, TNBC triple negative breast cancer